Oxadiazole derivatives with CRTH2 receptor activity

Details for Australian Patent Application No. 2006319462 (hide)

Owner 7TM Pharma A/S

Inventors Receveur, Jean-Marie; Grimstrup, Marie; Christensen, Ann; Hoegberg, Thomas

Agent Davies Collison Cave

Pub. Number AU-A-2006319462

PCT Pub. Number WO2007/062773

Priority 0524428.0 30.11.05 GB

Filing date 22 November 2006

Wipo publication date 7 June 2007

International Classifications

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/062773 Priority application(s): WO2007/062773

14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006319474-Laser transfer of security features

2006319440-Chemokine-mucin fusions linked to glycosylphosphatidylinositol (GPI)-anchors in tissue regeneration and as tumour immune adjuvants